US Stock MarketDetailed Quotes

Telomir Pharmaceuticals (TELO)

Watchlist
  • 1.330
  • +0.010+0.76%
Close May 5 16:00 ET
  • 1.346
  • +0.016+1.17%
Pre 04:33 ET
45.73MMarket Cap-4.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telomir Pharmaceuticals (TELO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-13.91%10.54M
-26.53%2.13M
-80.91%1.15M
243.84%5.07M
14.18%2.19M
210.55%12.24M
169.36%2.91M
529.48%6.01M
3.38%1.47M
296.75%1.92M
Selling and administrative expenses
-15.91%8.1M
-68.20%838.47K
-92.81%386.95K
471.46%5.03M
149.59%1.85M
1,505.54%9.64M
566.94%2.64M
5,163.42%5.38M
1,363.55%879.7K
1,640.58%741.54K
-General and administrative expense
-15.91%8.1M
-68.20%838.47K
-92.81%386.95K
471.46%5.03M
149.59%1.85M
1,505.54%9.64M
566.94%2.64M
5,163.42%5.38M
1,363.55%879.7K
1,640.58%741.54K
Research and development costs
8.96%2.44M
381.71%1.3M
21.05%759.53K
-92.80%42.84K
-58.09%337K
41.99%2.24M
32.04%269.08K
138.97%627.43K
-10.91%594.8K
82.59%804.02K
Other operating expenses
----
----
----
----
----
-79.04%370.5K
--0
----
----
--370.5K
Operating profit
13.91%-10.54M
26.53%-2.13M
80.91%-1.15M
-243.84%-5.07M
-14.18%-2.19M
-210.55%-12.24M
-169.36%-2.91M
-529.48%-6.01M
-3.38%-1.47M
-296.75%-1.92M
Net non-operating interest income expense
102.93%125.64K
940.61%73.49K
186.06%44.18K
-99.92%20
100.18%7.95K
-161.13%-4.29M
100.93%7.06K
102.04%15.45K
120.55%25.49K
-4.34M
Non-operating interest income
161.76%125.64K
921.10%72.1K
186.06%44.18K
-94.66%1.36K
----
--48K
--7.06K
--15.45K
--25.49K
----
Non-operating interest expense
--0
-138,700.00%-1.39K
--0
--1.34K
----
164.05%4.34M
-100.00%-1
--0
--0
--4.34M
Total other finance cost
----
----
----
----
-100.18%-7.95K
----
----
----
----
--4.34M
Other net income (expense)
Special income (charges)
----
----
----
----
----
--0
----
----
----
----
Income before tax
37.01%-10.41M
28.88%-2.06M
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
Income tax
Net income
37.01%-10.41M
28.88%-2.06M
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
Net income continuous Operations
37.01%-10.41M
28.88%-2.06M
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
Minority interest income
Net income attributable to the parent company
37.01%-10.41M
28.88%-2.06M
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.01%-10.41M
28.88%-2.06M
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
Basic earnings per share
41.07%-0.33
40.00%-0.06
85.00%-0.03
-240.00%-0.17
69.57%-0.07
-26.85%-0.56
68.25%-0.1
-246.04%-0.2
4.51%-0.05
-1,310.18%-0.23
Diluted earnings per share
41.07%-0.33
40.00%-0.06
85.00%-0.03
-240.00%-0.17
69.57%-0.07
-26.85%-0.56
68.25%-0.1
-246.04%-0.2
4.51%-0.05
-1,310.18%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -13.91%10.54M-26.53%2.13M-80.91%1.15M243.84%5.07M14.18%2.19M210.55%12.24M169.36%2.91M529.48%6.01M3.38%1.47M296.75%1.92M
Selling and administrative expenses -15.91%8.1M-68.20%838.47K-92.81%386.95K471.46%5.03M149.59%1.85M1,505.54%9.64M566.94%2.64M5,163.42%5.38M1,363.55%879.7K1,640.58%741.54K
-General and administrative expense -15.91%8.1M-68.20%838.47K-92.81%386.95K471.46%5.03M149.59%1.85M1,505.54%9.64M566.94%2.64M5,163.42%5.38M1,363.55%879.7K1,640.58%741.54K
Research and development costs 8.96%2.44M381.71%1.3M21.05%759.53K-92.80%42.84K-58.09%337K41.99%2.24M32.04%269.08K138.97%627.43K-10.91%594.8K82.59%804.02K
Other operating expenses ---------------------79.04%370.5K--0----------370.5K
Operating profit 13.91%-10.54M26.53%-2.13M80.91%-1.15M-243.84%-5.07M-14.18%-2.19M-210.55%-12.24M-169.36%-2.91M-529.48%-6.01M-3.38%-1.47M-296.75%-1.92M
Net non-operating interest income expense 102.93%125.64K940.61%73.49K186.06%44.18K-99.92%20100.18%7.95K-161.13%-4.29M100.93%7.06K102.04%15.45K120.55%25.49K-4.34M
Non-operating interest income 161.76%125.64K921.10%72.1K186.06%44.18K-94.66%1.36K------48K--7.06K--15.45K--25.49K----
Non-operating interest expense --0-138,700.00%-1.39K--0--1.34K----164.05%4.34M-100.00%-1--0--0--4.34M
Total other finance cost -----------------100.18%-7.95K------------------4.34M
Other net income (expense)
Special income (charges) ----------------------0----------------
Income before tax 37.01%-10.41M28.88%-2.06M81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M
Income tax
Net income 37.01%-10.41M28.88%-2.06M81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M
Net income continuous Operations 37.01%-10.41M28.88%-2.06M81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M
Minority interest income
Net income attributable to the parent company 37.01%-10.41M28.88%-2.06M81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.01%-10.41M28.88%-2.06M81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M
Basic earnings per share 41.07%-0.3340.00%-0.0685.00%-0.03-240.00%-0.1769.57%-0.07-26.85%-0.5668.25%-0.1-246.04%-0.24.51%-0.05-1,310.18%-0.23
Diluted earnings per share 41.07%-0.3340.00%-0.0685.00%-0.03-240.00%-0.1769.57%-0.07-26.85%-0.5668.25%-0.1-246.04%-0.24.51%-0.05-1,310.18%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.56%
Sample Name
Sample Code
 +14.20%
Sample Name
Sample Code
 +14.18%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+10.58%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.71%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +21.01%
Sample Name
Sample Code
 +20.15%
Sample Name
Sample Code
 +14.82%
4
ASE Technology
ASX
+11.17%
5
Luckin Coffee
LKNCY
+10.14%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report from AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has b Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -